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Abstract
Background: Yin Yang 1 (YY1) is a ubiquitously expressed GLI-Kruppel zinc finger-containing transcriptional
regulator. YY1 plays a fundamental role in normal biologic processes such as embryogenesis, differentiation, and
cellular proliferation. YY1 effects on the genes involved in these processes are mediated via initiation, activation, or
repression of transcription depending upon the context in which it binds. The role of the multifunctional
transcription factor Yin Yang 1 (YY1) in tissue development is poorly understood. In the present, we investigated
YY1a role in developing zebrafish on PSR-mediated apoptotic cell engulfment during organic morphogenesis.
Results: YY1a is first expressed 0.5 h post-fertilization (hpf), in the whole embryo 12 hpf, and in brain, eyes, and
heart 72 hpf by in situ hybridization assay. The nucleotide sequence of zebrafish YY1a transcription factor (clone
zfYY1a; HQ 166834) was found to be similar to that of zebrafish YY1a (99 % sequence identity; NM 212617). With
the loss-of-function assay, YY1a knockdown by a morpholino oligonucleotide led to downregulation of the
phosphatidylserine engulfing receptor zfPSR during embryonic segmentation and to the accumulation of a large
number of dead apoptotic cells throughout the entire early embryo, especially in the posterior area. Up to 24 hpf,
these cells interfered with embryonic cell migration and cell-cell interactions that normally occur in the brain, heart,
eye, and notochord. Finally, with gain-of-function assay, defective morphants could be rescued by injecting both
YY1a mRNA and PSR mRNA and trigger resumption of normal development.
Conclusions: Taken together, our results suggest that YY1a regulates PS receptor expression that linked to function
of PSR-phagocyte mediated apoptotic cell engulfment during development, especially the development of organs
such as the brain and heart. YY1a/PSR-mediated engulfing system may involve in diseases.
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Background
Yin Yang 1 (YY1; also called delta, NF-E1, and UCRBP) is a
ubiquitously expressed GLI-Kruppel zinc finger-containing
transcriptional regulator [1–4]. YY1 plays a fundamental
role in normal biologic processes such as embryogenesis,
differentiation, and cellular proliferation [5]. Its effects on
the genes involved in these processes are mediated via initi-
ation, activation, or repression of transcription depending
upon the context in which it binds. The activation or re-
pression can be direct via the disruption of binding sites or
the causing of changes in DNA conformation or indirect
via cofactor recruitment [6–12].
Since its original isolation, YY1 has been shown to
regulate an ever-growing number of viral and cellular
genes, including the human immunodeficiency virus
type 1 and human papillomavirus oncogenes E6 and E7,
several proto-oncogenes (c-myc, c-fos, and erb2), cdc-6,
the DNA replication-dependent histone H3.2 gene, and
others [13–16]. Transient transfection and/or in vitro
approaches have been used to characterize YY1 target
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genes, most of which have yet to be validated as YY1 tar-
get genes in vivo. Nevertheless, these studies suggest im-
portant roles for YY1 in the control of cell growth,
apoptosis, and oncogenic transformation.
Several lines of evidence suggest a critical requirement
for YY1 in embryonic development, morphogenesis, and
organogenesis. The Drosophila counterpart of YY1, pleioho-
meotic (pho), participates in embryonic patterning; muta-
tions of pho result in homeotic transformations associated
with misexpression of homeotic genes [17–19]. YY1 is also
essential for neural induction and patterning in Xenopus
laevis [20]. Constitutive ablation of YY1 in mice results in
peri-implantation lethality [21]. Mice heterozygous for the
YY1 gene (yy1+/−) display a mild developmental delay and a
subset of these animals exhibit neurulation defects and
exencephaly [21]. While these observations strongly suggest
that YY1 acts during late embryogenesis, early embryonic
lethality caused by constitutive loss of function has
precluded investigation of the YY1 requirement at later de-
velopmental stages [22]. Then, it was shown that YY1 over-
expression can reduce fetal troponin (ssTn1) expression in
neonatal myocardium [23] and promotes mesodermal car-
diac differentiation [24]. Recently, in the zebrafish system,
YY1a have examined on promoting the zebrafish liver stea-
tosis and lipotoxicity by inhibiting CHOP-10 exoression
[25] and regulating the zebrafish hematopoiesis by beta-
arrestin 1 via binding to YY1b and relieving polycomb
group repression [26]. Whether the YY1a involve in early
embryonic development is still uncover.
Apoptotic cell death occurs by a mechanism that has
been evolutionarily conserved from nematodes to humans
[27]. In vivo, apoptotic cells are typically engulfed and
degraded by phagocytes [28]. Removal of apoptotic cells
suppresses inflammation, modulates the macrophage-
directed deletion of host cells, and regulates the immune
response [29]. The phagocyte engages the dying cells
through surface receptors that include the phosphatidyl-
serine receptor (PSR) [30–32], Fc receptor, complement
receptors 3 and 4, the ABC1 transporter, members of the
scavenger-receptor family [33–36].
Morpholinos are chemically modified oligonucleotides
with base-stacking abilities similar to those of natural gen-
etic material [37]. Morpholinos have been shown to bind
to and block translation of mRNA in zebrafish cells [38].
Little is known regarding the part played by YY1a in
the clearance of cell corpses in zebrafish. In this present,
our aim was to define the genetic requirements for a
potentially distinct death paradigm involving YY1a in
zebrafish during early embryonic development.
Methods
Maintenance of fish embryos in culture
Techniques for the care and breeding of zebrafish have
been previously described in detail [39]. Embryos were
collected from natural matings and maintained in em-
bryo medium (15 mM NaCl, 0.5 mM KCl, 1 mM CaCl2,
1 mM MgSO4, 0.15 mM, 0.05 mM Na2HPO4, 0.7 mM
NaHCO3) at 28.5 °C. Embryos were staged according to
standard morphological criteria [40].
zfYY1a cloning
Synthesis and amplification of cDNA was carried out
using the SuperScript One-Step™ reverse transcriptase-
polymerase chain reaction (RT-PCR) system kit (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions.
YY1 primers P1 and P2 were each added to a final con-
centration of 0.2 μM. PCR cycling conditions were 54 °C
for 30 min, 2 min at 94 °C (to inactivate the reverse tran-
scriptase), 95 °C for 30 s (DNA denaturation), 57 °C for
30 s (annealing), and 72 °C for 60 s (extension) for a total
of 35–40 cycles. The RT-PCR primers—zebrafish YY1 P1:
5′-ATGGCGTCGGGCGAGACACTGT-3′ (22mer) and
YY1 P2: 5′-TCACTGATTGTTCTTAGCTTTCGCGTGT
GT-3′ (30mer)—were used to amplify a fragment covering
the complete mRNA region of YY1a. The purity and size
of the amplified product were verified by 1.5 % agarose gel
electrophoresis and staining with ethidium bromide [41].
The 1074-bp, double-stranded cDNA was purified using
the QIAquick™ gel extraction system (Qiagen, Valencia,
CA) and subcloned using a pGEMT-easy cloning sys-
tem (Promega, Madison, WI). The cloned PCR prod-
ucts were sequenced by the dye termination method
using an ABI PRISM 477 DNA sequencer (Applied
Biosystems, Foster City, CA) and their sequences were
scanned against the GenBank database BLAST
(www.ncbi.nlm.nih.gov/) and PROSITE (psort.ims.u-
tokyo.ac.jp/) programs.
GenBank was the source of the human homologue
(accession number NM 003403) and mouse homologue
(accession number NM 009537), and the complete se-
quences for Xenopus homologue (accession number NM
001093935), D. melanogaster homologue (accession num-
ber XM 002099609), and zebrafish homologue (accession
numbers NM 212617 and HQ166834).
Morpholinos
All morpholinos (Gene Tools, LLC, Corvallis, OR) were ar-
bitrarily designed to bind to sequences flanking and includ-
ing the initiating methionine. We selected sequences based
on design parameters recommended by the manufacturer
(21–25mer antisense), and looked for the presence of each
designed sequence elsewhere in the genome [37, 38]. Se-
quences were as follows (the sequence complimentary to
the predicted start codon is underlined in all cases): YY1-
MO-5′-gTACAgTgTCTCgCCCgACgCCAT-3′.
Control-MO-5′-5′-gTACACTgACgCgCgCgTCgCCAT-3′.
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(The five sites in the control-MO sequence that are
subject to point mutation in the YY1-MO sequence are
shown in shaded blocks.)
Injection of YY1a morpholino oligonucleotides
Morpholino oligonucleotides were dissolved in water at
a concentration of 1 mM and diluted with water to 0.5,
0.25, and 0.125 mM prior to injection (1.5–3 nl) into the
yolk [42].
In-situ hybridization
Digoxigenin-labeled antisense RNA probes were synthe-
sized from linearized DNA templates containing YY1a,
psr, pax2a, and nkx2.5, using T7 RNA polymerase
(Boehringer Mannheim, Mannheim, Germany). Whole-
mount in-situ hybridizations were performed as previ-
ously described [43]. In-situ hybridization was used to
analyze YY1a mRNA expression in embryos injected
with YY1-MO or control-MO at 0.5 h post-fertilization
(hpf ), 12 hpf, 24 hpf, 48 hpf, and three days pf (3 dpf ).
Apoptotic cell staining during embryonic development
Embryos at the one- or two-cell stage were injected with
YY1-MO (25 ng) or control-MO (25 ng) or YY1-MO
(25 ng) plus PSR mRNA (1 ng), harvested at 18.5 hpf,
fixed with 4 % paraformaldehyde in PBS (pH 7.4) at
room temperature for 30 min, stained with acridine or-
ange (1 μg.ml−1; 3–5 min), washed twice in PBS, and
evaluated under a fluorescence microscope (using a 488-
nm filter for excitation and a 515-nm long-pass filter for
detection) [44]. For the TdT-dUTP labeling step, the
embryos were fixed in paraformaldehyde at the end of
the incubation period (12 and 24 hpf), dechorionated,
incubated in blocking solution (0.1 % H2O2 in methanol,
30 min, room temperature), rinsed with PBS, incubated
on ice in 0.1 % Triton X-100 in 0.1 % sodium citrate for
30 min to increase permeability, rinsed twice with PBS,
treated with TUNEL reaction mixture (50 μl; in-situ cell
death-detection Kit, Boehringer Mannheim), incubated in
a humidified chamber for 60 min at 37 °C, and evaluated
for fluorescence-positive apoptotic cells under a fluores-
cence microscope equipped with a spot II CCD camera
(Diagnostic Instruments, Inc., Sterling Heights, MI).
Western blotting
Embryos were injected with YY1-MO or control-MO at
the one- or two-cell stage, harvested 24 hpf, and lysed in
150–200 μl of sodium dodecyl sulfate (SDS) sample buffer
(0.63 ml of 1 M Tris–HCl, pH 6.8, 1.0 ml of glycerol,
0.5 ml of ß-mercaptoethanol, 1.75 ml of 20 % SDS, 6.12 ml
of H2O in 10 ml total). Protein (40 μg) from 24-hpf em-
bryos was loaded onto each lane. Standard western-blot
analysis was conducted using human anti-YY1 Mab
(Cascade Bioscience, Winchester, MA), anti-zebrafish
PSR N-terminus polyAb (self-made), and mouse anti-actin
Mab (Chemicon, Temecula, CA). PSR was visualized
using horseradish peroxidase-conjugated anti-mouse
immunoglobulin (IgG) and the ECL detection kit
(Amersham Pharmacia Biotech, Denmark) [44].
Microinjection of PSR mRNA rescues YY1a-mediated de-
fective morphants
Zebrafish YY1a and PSR [31] were cloned into the
pCDNA3 vector, which contains a T7 RNA polymerase
promoter site. Linearized plasmid DNA was used as a
template for in vitro transcription carried out using the
Message Machine Kit (Ambion Inc, Austin, TX), accord-
ing to the manufacturer’s instructions. For rescue of de-
fective morphants, either 0.1 nl of 200 ng/μl mRNA
encoding soluble YY1a mRNA or 0.1 nl of 80 and
40 ng/μl mRNA encoding soluble PSR mRNA and YY1-
MO (0.5 μM) were injected into the one-cell stage of
each embryo using a gas-driven microinjector (Medical
System Corp, Greenvale, NY) [42].
Quantitative (q)RT-PCR
Embryos at the one- or two-cell stage were injected with
YY1-MO (25 ng) or control-MO (25 ng) or YY1-MO
(25 ng) plus PSR mRNA (1 ng), harvested at 18.5 hpf. The
mRNA expression levels were measured by a qRT-PCR
with a Roche Lightcycler Nano (Roche, Penzberg,
Germany). The final volume in a well was 20 ul, and con-
tained 4 ul of OmicsGreen qPCR 5X master mix (Omics
Bio, Taipei, Taiwan), 3.2 ng of cDNA, and 50 nM of primer
pairs. Cycling parameters were as follows: 95 °C × 900 s,
then 45 cycles of the following 95 °C × 15 s, 60 °C × 20 s
and 72 °C × 20 s. The standard curve of each gene was
checked in the linear range with ß-actin as internal
controls. The primer sets are given as follows: P53
primer-forward 5′-ACCACT GGGACCAAACGT AG-3′;
Primer-reversed - 5′-CAGAGTCGCTTCTTCCTTCG-3′.
Results
YY1a cloning and determination of functional domains
YY1a was cloned using a specific primer from the 24-
hpf total mRNA. The sequences of positive clones were
used to search GenBank databases. Some significant
matches were made after translating the nucleotide se-
quences (1074 bp) to amino acid sequences (357 aa)
(Fig. 1a). The molecular weight (Fig. 1a) for zfYY1,
39.8 kDa, was predicted from its amino acid sequence.
The nucleotide sequence of zebrafish YY1a (zfYY1)
(HQ 166834) had 99 %, 92 %, 98 %, 98 %, and 98 %, re-
spectively, identity with zebrafish YY1a (NM 212617),
and the YY1s for D. yakuba (XM 002099609), human
(NM 003403), mice (NM 009537), and Xenopus laevis
(NM 001093935). Here, we named zfYY1 (HQ 166834)
gene is equal to YY1a (NM 212617) gene.
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In addition, there were two consensus sequences for the
nuclear localization signals within YY1a—a 7-amino-acid
peptide (PSGRMKK; at 118–124 aa) and a 7-amino-acid
peptide (PRKIKED; at 227–233 aa) (Fig. 1a, box A1-2).
Domains of potential zinc finger proteins, CH2H2
type, corresponding to residues 241–263 (box B1;
CPHKGCTKMFRDNSAMRKHLHTH, 23 aa), 270–290
(box B2; CAECGKAFVESSKLKRHQLVH, 21 aa), 298–320
(box B3; CTFEGCGKRFSLDFNLRTHVRIH, 23 aa), and












































































































Fig. 1 Sequence alignment of zebrafish YY1a and its expression profile. a A sequence alignment of the YY1a protein (where positions of the
functional domains are indicated by a series of boxes labeled A–C). Box A contains potential nuclear localization signals (PSGRMKK [118–124 aa] and
PRKIKED [227–233 aa]; Fig. 1a, box A1-2). These lie within the predicted intracellular domain (SMART-TMHMM2 program). Box B1–4 contains the
potential zinc finger, CH2H2 type, domains (box B1 [CPHKGCTKMFRDNSAMRKHLHTH, residues 241–263, 23 aa], box B2 [CAECGKAFVESSKLKRHQLVH,
residues 270–290, 21 aa], box B3 [CTFEGCGKRFSLDFNLRTHVRIH, residues 298–320, 23 aa], and box B4 [CPFDGCNKKFAQSTNLKSHILTH, residues 328–350,
23 aa]), all of which are well characterized as DNA binding modules. Box C (residues 353–356; AKNN for KKXX domain) contains an ER membrane
retention signal based on architectural analysis performed with the SMART-TMHMM2 program. b Expression of YY1a from early to late developmental
stages detected by in-situ antisense RNA hybridization. YY1a was visualized by blue staining. Lateral view of embryos is shown in panels a–c and e; top
view is shown in panel d; anterior is on the right side. (a) One-cell stage (half-hour). YY1a is expressed in all cells examined. b At 12 hpf, YY1a is
expressed throughout the embryo. (c) At 24 hpf, YY1a is expressed throughout the embryo, but is especially concentrated within the brain region
(indicated by an arrow) and in the anterior part of the embryo. (d) At 48 hpf, YY1a is expressed principally in the posterior notochord (indicated by an
arrow) and secondarily in the trunk, brain, kidney, and eyes (indicated by arrows). (e) At 3 dpf, the YY1a is strongly expressed in some major organs
(brain, heart, and eyes; indicated by arrows) and mildly expressed throughout the somite. Scale bars denote 100 μm
Shiu et al. Journal of Biomedical Science  (2016) 23:31 Page 4 of 14
aa), which are well-known DNA binding sequences, are
shown in box B1–4 (Fig. 1a). The sequence shown in
Fig. 1a, box C (residues 353–356; AKNN for KKXX
domain) was identified as an endoplasmic reticulum
membrane retention signal.
YY1a expression pattern
YY1a was expressed from the one-cell developmental
stage (30 min) to the 3-day pf (3 dpf ) larval stage (Fig. 1b,
panels a–e). After somite segmentation, YY1a was appar-
ent throughout the embryo (Fig. 1b, panels b–d) and the
brain (Fig. 1b, panels b–d). At the 3-dpf larval stage, YY1a
expression was detected in the brain, heart, and eye
(Fig. 1b, panel e).
YY1a knockdown affects apoptotic cell accumulation and
delays epiboly
YY1a morpholino oligonucleotides (MO; 25 ng) were
injected into embryos to knock down YY1a expression
(Fig. 2) that morpholino oligonucleotides is localized
from the ATG start site for covering the 24 nt. Acridine
orange staining revealed the accumulation of corpse
cells 18.5 hpf in the brain, interior somite, and tail bar
(indicated by arrows, Fig. 2b and d; Fig. 2a and c, the
control), while TUNEL staining revealed apoptotic cells
throughout the embryo at 18.5 hpf (Fig. 2f; Fig. 2e, the
control). Then, we checked the cell death-related gene,
P53 by qRT-PCR approach as a control at 18.5 hpf
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*
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Fig. 2 Apoptotic cell analysis by AO staining and TUNEL assay. Control-MO and YY1-MO (25 ng per embryo) were injected at the one-cell stage
to block translation of YY1a mRNA. The embryos were fixed and observed at the different stages postfertilization (pf). The AO-stained embryos
are shown in a (Control-MO; 18.5 hpf), b (YY1-MO; 18.5 hpf), c (Control-MO; 18.5 hpf; enlarged from A), and d (YY1-MO; 18.5 hpf; enlarged from B;
strongly AO-positive cells indicated by arrows). TUNEL stained embryos (all at 18.5 hpf) are shown in e (Control-MO) and f (YY1-MO group).
Identification of apoptotic cell death-related gene P53 at 18.5 hpf by qRT-PCR approach as a control is shown in (g). All data were analyzed using either
paired or unpaired Student’s t-tests as appropriate. *P < 0.01. The TUNEL-positive cells under the fluorescence microscope are considered apoptotic.
Bars indicate 100 μm
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YY1a knockdown early in the epiboly stage strongly af-
fected embryonic development at 8 hpf, caused a severe
delay in epiboly migration (indicated by red arrows)
about 20 % (Fig. 3b; cf Fig. 3a [control MO-injected em-
bryo]), which led to accumulation of some cells in margin
layer. Then, the delay epiboly migration embryos was
counted that is shown 18 % different (Fig. 3c) in injection
embryos (N = 60).
Influence of cell corpses on normal embryonic
development
We next tested the ability of the YY1-MO and control-
MO to block translation of zfYY1a. As shown in Fig. 4a
(panel a), injections of 25 ng of YY1-MO blocked 65 %
(lane 3) of the control-MO protein expression (lane 2)
and wild-type protein expression (lane 1). The molecular
weight of zebrafish YY1a (evident in lanes 1–4) was
43 kDa, which was smaller than that of the positive con-
trol (about 45 kDa for HeLa cell lysate; Fig. 4a, panel b).
At 12 hpf, the YY1-MO-injected (25 ng) embryos were de-
fective reflecting a delay in epiboly (Fig. 4b, c, as indicated
by arrows; cf. with Fig. 4b, a [wild type] and Fig. 4b, b
[control MO injection]), a loss of normal morphogenetic
capability, and abnormal YY1a expression (Fig. 4b, panel f,
as indicated by arrows; cf. with Fig. 4b, d [wild type] and
Fig. 4b, e [control MO injection]). These changes were
also evident at 48 hpf (Fig. 4b, i, as indicated by arrows; cf.
with Fig. 4b, g and h [control]).
The abnormalities at 48 hpf were both mild (just
shown mild defects in brain and heart but can hatching
out) and severe (severe defects in brain and heart, and
did not hatching out) (Fig. 4c, c and d; cf. with Fig. 4c, a
and b [wild type and control MO-injected]). The mild
defects included abnormal mid- and hindbrain morph-
ology or a slight delay in heart development prior to
hatching (Fig. 4c, panel c; as indicated by arrows). The
severe defects included marked delays in development
manifesting as shrinkage of the brain, defects in heart
development, and failure to hatch (Fig. 4c, panel d; as in-
dicated by arrows).
YY1-MO dosage from 12.5 ng (n = 174), 25 ng (n = 178),
to 50 ng (n = 174) was significantly correlated with develop-
mental change (compare with control-MO injection
[n = 126]) at 48 hpf as shown in Table 1.
YY1a knockdown downregulates PSR expression
To determine whether YY1a knockdown affects expres-
sion of PSR (a mediator of apoptotic cell engulfment by
macrophages) was investigated. As shown in Fig. 5a, in-
jections of 25 and 50 ng of YY1-MO blocked 50 % (lane
2) and 90 % (lane 3) of PSR expression (compared with
lane 1 [control MO, 50 ng, normal control]) at 24 hpf.
We found that YY1-MO (25 ng) injection apparently
reduced PSR expression throughout the embryo (Fig. 5b,
c, as indicated by arrows; cf. with Fig. 5b, a [wild type]
and Fig. 5B, b [control MO injection]) at 12 hpf and re-
duced PSR expression in brain and somites (Fig. 5b, f, as
indicated by arrows; cf. with Fig. 5b, d [wild type] and
Fig. 5b, e [control MO injection]) at 24 hpf. The changes
at 24 hpf were still present at 48 hpf (Fig. 5b, i, as indi-
cated by arrows; cf. with Fig. 5b, g and h [control]).
YY1a involvement in brain and heart organogenesis
Brain and heart development was monitored using marker
genes for the brain pax 2a [45] and heart nkx 2.5 [46] at
24, 48, and 72 hpf. Significant differences were apparent at
12 and 24 hpf (data not shown). In brain development
study, the developing mid- and hindbrains appeared to
shrink and express abnormal amounts of pax 2a at 48 hpf
(Fig. 6a, c; as indicated by arrows; cf. with Fig. 6a, a [wild
type] and Fig. 6a, b [normal control]). At 3 dpf, YY1-MO
morphants were apparently shorter and their mid- and
hindbrains apparently smaller by about 2-fold (Fig. 6a, f;





Fig. 3 Morpholino-induced knockdown of YY1a prevents cell corpse
engulfment and cell migration. a Control-MO-injected embryos, lateral
view of a Control-MO-injected embryo about entering into 70 % epiboly
stage at 8 hpf (indicated by arrows) reveals the normally developed.
b Lateral view of a YY1-MO-injected embryo reveals the delay
epiboly about 20 % (indicated by red arrows). Bars indicate
100 μm. c Quantification of the delay epiboly embryos from
control-MO and YY1-MO injection groups is shown the delay
epiboly migration (N = 60)
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In heart development study, probing with nkx 2.5
allowed the monitoring of heart morphogenesis. In-situ
assay using nkx 2.5 as probe detected a severe delay in
heart development (atria absent from a tube-like heart;
Fig. 6b, c; cf with Fig. 6b, a [wild type] and b [control
MO injection]) at 48 hpf and presence of a tube-like
heart (twice the normal size in length) and abnormal
blood circulation rate (Fig. 6b, f; cf. with Fig. 6b, d [wild
type] and e [control MO injection]) at 3 dpf.
YY1a mRNA rescues defective morphants
The results of 2.5 ng of YY1a mRNA prevented the devel-
opmental block due to coinjection of YY1-MO with 25 ng
of YY1-MO at the embryonic one- or two-cell stage. In
the present study, the same result was obtained by inject-
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Fig. 4 Ubiquitous YY1a inhibition by injection of morpholinos (YY1-MO). a Western-blot analysis of YY1a proteins in the 24-h stage wild type
embryos and YY1-MO-injected embryos. The knockdown of YY1a gene in these embryos by YY1-MO injection was shown in panel a, lane 3 (panel a,
lanes 1–3; panel b, the positive control, HeLa cell lysate). Actin was the loading control. b Each one-cell stage embryo was injected with either 25 ng of
control-MO or 25 ng of YY1-MO. At 12, 24, and 48 hpf, embryos were fixed and examined after in-situ hybridization. The phase-contrast images of the
wild type (panels, a, d, and g) and control-MO-injected (panels b, e, and h) embryos show normal development and YY1a expression patterns. However
those of the YY1-MO-injected embryos show abnormal development (panels c, f and i) and delayed YY1a expression (panel c, 12 hpf; arrows)
and abnormal YY1a expression (panel f and i; 24 and 48 hpf, respectively; arrows). c Phase-contrast images of wild type embryos (panel a),
control-MO-injected embryos (panel b), YY1-MO-injected embryos that are slightly affected (panel c), and YY1-MO injected embryos that are
severely affected (panel c). The abnormal brain and heart are indicated by arrows. Bars indicate 250 μm
Table 1 Percentage of morphant phenotypes during
knockdown of YY1a by YY1-morpholines
Phenotypea Control-MO YY1-MO
50 ng 12.5 ng 25 ng 50 ng
Number of embryos 126 174 178 174
Normal type 92.0 % 40.0 % 5.6 % 1.3 %
Weakly defective 8.0 % 41.7 % 10.2 % 3.6 %
Severely defective 8.0 % 20.2 % 7.3 %
Death type 10.3 % 64.0 % 87.8 %
aAll embryos were examined at 2 dpf
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YY1-MO-injected embryos had mild and severe de-
velopmental defects (Fig. 7a, c) at 48 hpf. After rescue,
embryos had only mild defects at 48 hpf (Fig. 7a, d; cf.
with Fig. 7a, a [wild type] and b [control MO injec-
tion]). Both mild and severe defects were evident at 3
dpf Figs. 4c, c and d) and no defects were evident in
the controls (Fig. 7a, e [wild type] and f [control MO
injection]).
Survival and morphant phenotype rates were estimated
in wild type (n = 215), control-MO (n = 136), YY1-MO
plus YY1a mRNA (n = 171), and YY1-MO (n = 185) em-
bryos at 3 dpf. The rate of severe defect occurrence was
reduced from 27.5 % to 5 % and the rate of mild defect oc-
currence was reduced from 45 % to 11 % by injection of
the YY1a mRNA (Fig. 7b). Rescue restored morphogenesis
and brain-heart development to normal (Figs. 7c, d; cf.
with wild type [Fig. 7c, a] and control-MO injected em-
bryos [Fig. 7c, b]) at 3 dpf. The YY1-MO-injected embryos
with slight reduction in brain size and heart development
had patterns of morphogenesis and YY1a expression that
reflected these mild deformities (Figs. 7c, c; as indicated
by arrows; cf. with Fig. 7c, a [wild type] and Fig. 7c, b
[control MO injection]).
PSR mRNA rescues YY1a-mediated defective morphants
To determine extra reloading PSR mRNA whether can
rescue YY1a defected. The 0.5 ng or 1 ng of PSR mRNA
were used to coinjection of YY1-MO with 25 ng of PSR-
MO at the embryonic one- or two-cell stage.
The rescued group (1 ng of PSR mRNA is better than
0.5 ng) was co-injected into embryos with 25 ng of YY1-
MO (Fig. 8a). TUNEL staining revealed the accumulation
of corpse cells 18.5 hpf in the whole embryo, especially
the somite (Fig. 8a:b; indicated by arrows) in YY1-MO
group, when compared with Wild type (Fig. 8a:a) and PSR
mRNA-rescued group (Fig. 8a:c), which also shown the
very few accumulation of corpse cells in the somite (indi-
cated by arrow).














Fig. 5 Morpholino-induced knockdown of YY1a results in down-regulation of PS receptor at 24 hpf. a Western-blot analysis of PSR proteins in
lysates of YY1-MO-injected embryos. Note that PSR protein level in these embryos decreases in a YY1-MO dose-dependent manner (Fig. 5a, panel
a, lane 1 [control-MO, 50 ng]; lane 2 [YY1-MO, 25 ng], and lane 3 [YY1-MO, 50 ng]). Panel b shows the actin loading control. b One-cell stage
embryos were each injected with either 25 ng of control-MO or 25 ng of YY1-MO. At 12, 24, and 48 hpf, embryos were fixed and in-situ hybridization
was performed as described in the Methods section. Phase-contrast images show normal development and psr expression patterns in wild type
(panels a, d, and g) and control-MO-injected (panels b, e, and h) embryos but abnormal development (panels c, f, and i) and either a mild (panel c,
12 hpf) or severe (panel f, 24 hpf; panel i, 48 hpf) delay in psr expression (arrows) in YY1-MO-injected embryos. Bars indicate 100 μm
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YY1-MO-injected embryos had severe developmental
defects (Fig. 8b:b, e and h) at 24 h, 48 h and 72 hpf, re-
spectively. After rescue, embryos had just mild defects at
72 hpf in the heart (Fig. 8b:i; indicated by arrow). And no
defects were evident in the controls (Fig. 8b, g [control
MO injection]).
After rescued by PSR mRNA, the normal type
(Fig. 8c; 3 dpf ) and morphant phenotype rates were
estimated in control MO (n = 210), YY1-MO (n = 178),
and YY1-MO plus PSR mRNA (1 ng; n = 207) embryos
at 3 dpf. The rate of normal type occurrence was sig-
nificantly increased from 19 % to 42 % (1 ng of mPSR
group), which can enhance up to 23 % in normal type.
The rate of mild defect occurrence was the same from
38 % to 38 % and the rate of severe (strongly) defect
occurrence was reduced from 43 % to 20 % by injec-
tion of the PSR mRNA (Fig. 8c), which can reduce up
to 23 % that was shown up (YY1a)-and-downstream
(PSR) relationship.
Discussion and conclusion
Phagocytosis plays an important role in inflammation and
autoimmune responses [29], [47, 48], and in remodeling
of tissue during development [49]. The link between
phagocytosis and development thus provides a useful sys-
tem to identify genes involved in phagocytosis. These
genes have been difficult to identify in mammalian sys-
tems [50]. While some questions remain, PSR appears to
play a central role in the clearance of apoptotic cells [51].
In the present, transcriptional factor YY1a played a posi-
tively regulator in the PSR gene expression that PSR-
mediated engulfment of cell corpses required for normal
embryonic development and tissue morphogenesis.
A
B
Fig. 6 Morpholino-induced knockdown of YY1a results in brain and heart defects. Morphological analysis of embryos injected with either 25 ng
of control-MO or YY1-MO and examined at 48 hpf or 3 dpf following staining with pax 2a, nkx 2.5, or no stain. a Panels a–c. The embryos are
stained with pax 2a (a, b; top view, anterior to the right) or not stained (d–f; lateral view). The YY1-MO-injected embryos (panel c) has smaller
brain (indicated by black arrow) and abnormal pax 2a pattern (indicated by red arrow) as compared with wild type embryos (panel a) and con-
trol-MO-injected embryos (panel b). The fore-, mid-, and hindbrains are shorter (indicated by open square [panel f]; cf. with control [panels d and e]). b
Staining with nkx 2.5 was used to monitor heart development. Normal heart formation was delayed at 48 hpf (panel c; indicated by star). Compare with
the atria (A) and ventricles (V) in panels a and b. The tube-like heart in panel f (indicated by arrows) should be compared with that in wild type and
control-MO-injected embryos (panels d and e, respectively) at 3 dpf. Bars indicate 100 μm
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PSR and others receptors involved in cell corpse
engulfment during development
The phagocytic removal of apoptotic cells suppresses in-
flammation, modulates the macrophage-mediated deletion
of host cells, and critically regulates the immune response
[29] in higher organisms. In vertebrates, the phagocyte en-
gages dying cells through specific receptors such as the
phospatidylserine receptor (PSR) [30–32]—a professional
receptor in zebrafish, but not in Drosophila system. Some
receptors involved in phagocytosis (e.g., Fc receptors, com-
plement receptors 3 and 4, the ABC1 transporter, members
of the scavenger-receptor family [33], and BAI1 [34] are
not expressed in the early embryonic stage. Recently, the
gene encoding Satblin-2 receptor [35] was found to be
expressed very early in embryonic development (before 5.4
hpf), but whether regulation by YY1 influences its expres-
sion remains unknown. On the other hand, a new corpse
engulfment receptor TIM4 [37] was found to be expressed
late (72 hpf) but not early in the embryonic development
of zebrafish, so this receptor may not be involved in early
corpse engulfment. In our system, we found that PSR-
mediated death cell clearing is important for normal devel-
opment and especially on brain and heart development that
can regulate by YY1a in the up-streaming.
B C
A
Fig. 7 Injection of YY1a mRNA rescued embryos from YY1a morpholino-induced defects. YY1-MO (25 ng) and YY1a mRNA (2.5 ng) were co-injected
at the one-to-two cell stage, and embryos were assessed at 48 hpf and 3 dpf. a Panel c shows YY1-MO-injected embryos with severe morphological
deformities (indicated by long arrow). After rescue, the deformities were markedly reduced (panel d: indicated by short arrow; cf. wild type [panel a]
and control-MO-injected [panel b] embryos). Bars indicate 250 μm. Whole embryos before (panel g) and after (panel h) rescue can be compared with
wild-type (panel e) and control-MO-injected (panel f) embryos. Bars indicate 200 μm. b The ability of YY1a mRNA injection to rescue embryos from
morphological deformities during development at 3 dpf was estimated. c Rescued embryos show normal morphology and normal YY1a expression in
the brain, heart, and somites and are all stained with the YY1a probe at 3 dpf developmental stage. The normal morphology and normal YY1a pattern
in the brain and heart (indicated by arrows) seen in rescued embryos (panel d) is in contrast to the deformed brains and hearts seen in YY1-MO
knockdown embryos (panel c; indicated by arrows). The wild type (panel a) and control-MO-injected (panel b) are the negative controls. Bars
indicate 200 μm
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YY1a knockdown can affect dead cell engulfment and
embryonic phenotype
In our present, first reported abnormal development
after knockdown of YY1 was monitored over time. Three
embryonic phenotypes (mildly defective, severely defect-
ive, and dead embryos) could be differentiated at 12, 24,
48, and 72 hpf. Mild defects (enlarged heart cavity and
brain malformation) were apparent at 48 hpf but not at
12 hpf. Severe defects at 12 hpf were associated with ac-
cumulation of a large number of apoptotic corpses
throughout the embryo that interfered with epiboly and
posterior development and their persistence at 48 hpf
led to failure to hatch and death at 3 dpf. This pattern
resembled that of embryos subjected to PSR knock down
[31]. Interestingly embryos could be prevented from de-
veloping mild and severe defects by injecting YY1
mRNA at 48 h and 72 hpf (Fig. 7) and PSR mRNA at
24 h, 48 h and 72 hpf (Fig. 8b and c) as a downstream
regulating gene, indicating that such an injection could
potentially be used to correct YY1a gene defects.
New role of YY1a affect PSR expression on engulfing
apoptotic cell function
Recently, it was shown that YY1 can direct targeting by
miR-34a [52]. Constitutive ablation of YY1 in mice has




Fig. 8 Injection of PSR mRNA rescued embryos from YY1a morpholino-induced defects. YY1-MO (25 ng) and PSR mRNA (1 ng) were co-injected
at the one-to-two cell stage, and embryos were assessed at 18.5 hpf, 48 hpf and 3 dpf. a Apoptotic cell analysis by TUNEL assay. Control-MO and
YY1-MO (25 ng per embryo) or YY1-MO (25 ng per embryo) plus PSR mRNA (1 ng) were injected at the one-cell stage to express extra PS receptor. The
embryos were fixed and observed at the different stages postfertilization (pf). TUNEL stained embryos (all at 18.5 hpf) are shown in A:a (Control-MO),
A:b (YY1-MO group) and A:c (extra PSR mRNA group). The TUNEL-positive cells under the fluorescence microscope are considered apoptotic, especially
in A:b (indicated by arrows). Bars indicate 100 μm. (B) Rescued embryos show normal morphology in the brain, heart, and somites. The normal
morphology in the brain and heart (indicated by arrows) seen in rescued embryos (panel c, at 24 hpf; f, at 48 hpf; i, at 72 hpf) is in contrast to the
deformed brains (indicated by black arrows) and hearts (indicated by red arrows) seen in YY1-MO knockdown embryos (panel b, at 24 hpf; e, at 48 hpf;
h, at 72 hpf; indicated by arrows). The control-MO-injected (panel a, at 24 hpf; d, at 48 hpf; g, at 72 hpf) are the negative controls. Bars indicate 200 μm.
c The ability of PSR mRNA injection to rescue embryos from morphological deformities during development at 72 hpf was estimated
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[21]. Heterozygous mice (yy1+/−) display a mild delay in
development, and a subset of these animals exhibit neurula-
tion defects and exencephaly [21]. While these observations
strongly suggest that YY1 acts during late embryogenesis,
the early embryonic lethality caused by constitutive loss of
function precludes investigation of the YY1 requirement at
later developmental stages [22]. Furthermore, DNA array
analysis of the response to conditional allele knockout of
YY1 gene in mouse embryonic fibroblasts [22] identified
about 135 up- and downregulated genes involved in (1)
cell cycle control, (2) mitosis and cytokinesis, (3) DNA
replication and repair, (4) apoptosis, (5) cell growth and
proliferation, and (6) development. In zebrafish system,
we found that zfYY1a knockdown can reduce PSR
mRNA and protein expression levels. Furthermore, we
found that zfYY1a-mediated defected could be rescued
by mPSR injection at 24 h, 48 h and 72 hpf (Fig. 8b and
c). Thus, YY1 may play a new role that act as a positive
regulator of PSR in the up-streaming during early em-
bryonic development.
Why is important of YY1a-mediated PSR clearing system
on brain and heart morphogenesis
The normal development is important for tissues or or-
gans completely formation that involved in turn on the
programmed cell death and engulfing of corpses cell
system, those events were tightly control and regulated,
if somewhere connection was mistaken or failed that
also caused the abnormal development and diseases.
We proposed that YY1a/PSR-mediated engulfing system
is important for this role.
The above-mentioned evidence supports our idea that
the accumulation of cell corpses interferes with normal
embryonic development by altering cell movement (Figs. 3b
and c) in early epiboly stage during normal genetic program
process.
From the developmental view, at the mid-blastula stage
(5.25 hpf), the gastrula starts to emerge, all cells acquire
the ability to move [40] (ZFIN website), and programmed
cell death/apoptosis is turned on [31]. Development re-




cells by PSR system
(start from 5.4 hpf)
Cell migration in 
epiboly
(5.4-10 hpf)
Completed organs development (10-72 hpf)
Brain HeartEyes Muscle Liver Lungs
PS receptor strongly expression
Clearance of corpse cells by PS receptor
Schematic diagram of YY1a regulation on PS receptor expression during development  
Rescued by YY1a and PSR mRNA
during knockdown of YY1a
Fig. 9 The schematic of our hypothesis on YY1a-mediated PSR engulfing dead cell system affects normal embryonic development and organogenesis.
Development begins at the completion of the first zygotic cell cycle (0–0.5 h; YY1a and PSR genes also were expressed), proceeds to the cleavage
stage (0.75 h) and then to cell cycles 2–7, which occur rapidly and synchronously. During the gastrula stage, three germ layers are formed (5.25 hpf).
At this point, the cell mobility is needed for epiblast, hypoblast, and embryonic axis formation through to the end of epiboly. Apoptosis can occur
during the early shield-stage gastrula, but cell corpses are removed promptly through PS receptor-mediated engulfment about starting at 5.4 hpf,
which may be regulated by transcription factor zfYY1a. If not removed, the cell corpses accumulate gradually and progressively impede cell movement
necessary for triggering downstream developmental events. Cells in the three germ layers (ectoderm, mesoderm, and endoderm) participate in
segmentation (10 h), leading to development of somites, pharyngeal structures, primordia, and neuromeres, which is necessary for primary
organogenesis and proper appearance of the tailbud. A disturbance at this early stage influences organogenesis at later stages (i.e., the pharyngula
[24 h], hatching [48 h], and early larval [72 h] stages). YY1a knockdown induced morphant defects that are also corrected by extra YY1a mRNA and PSR
mRNA injection at one cell or two cell stage
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occur including epiboly, involution, convergence, and ex-
tension [53–55]. If the apoptotic cell corpses are not
quickly removed by professional engulfing PSR-mediated
clearance system [31], they can impede cell movement
and delay epiboly and thereby the onset of organ develop-
ment such as on three germ-layers development for ecto-
derm, mesoderm and endoderm formations. Cells involved
in the development of somites, primordial pharyngea,
neuromeres, primary organs, and the tailbud are typically
associated with one of three germ layers (ectoderm, meso-
derm, or endoderm) [40, 53]. Cell corpses typically affect
morphogenesis of normal organs at the pharyngula (24 h),
hatching (48 h), and early larval (72 h) stages.
Recently, this is new emergence area that mechanic
forces induced by accumulated dead cells [56–58] that
the phagocyte engages the dying cells through phospha-
tidylserine receptors (PSR) and other receptors [30–32].
Here, we found that PSRs are professional receptors for
phagocytosis in zebrafish [31] between at 5.4hpf and 6
hpf that PSR-mediated engulfing pathway regulated by
YY1a.
Summary (Fig. 9)
The first traced the transcription factor YY1a as a ma-
terial factor was expressed from 0.5 hpf to 3 dpf. This
factor can regulate downstream molecule PS receptor
expression for engulfing of corpse cells during priming
the programmed cell death at about 6 hpf. With PSR-
mediated engulfing system for completed to clean the
death cells during early development that is important
for three germ layers formation and then tissue and organs
development. If it didn’t smooth process that defected em-
bryos especially on brain and heart developments also
found at late development stage. So YY1a/PSR-mediated
engulfing system is very important for normal develop-
ment and may cause diseases.
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